These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36473681)

  • 1. Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect process.
    Devlin SM; O'Quigley J
    Contemp Clin Trials; 2023 Feb; 125():107043. PubMed ID: 36473681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical guide to understanding Kaplan-Meier curves.
    Rich JT; Neely JG; Paniello RC; Voelker CC; Nussenbaum B; Wang EW
    Otolaryngol Head Neck Surg; 2010 Sep; 143(3):331-6. PubMed ID: 20723767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator.
    Ogłuszka M; Orzechowska M; Jędroszka D; Witas P; Bednarek AK
    Comput Methods Programs Biomed; 2019 Aug; 177():133-139. PubMed ID: 31319941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing Time-Varying Effect in Survival Analysis: 5 Complementary Plots to Kaplan-Meier Curve.
    Huang Q; Tian C
    Oxid Med Cell Longev; 2022; 2022():3934901. PubMed ID: 35391933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cautionary Note on Extended Kaplan-Meier Curves for Time-varying Covariates.
    Sjölander A
    Epidemiology; 2020 Jul; 31(4):517-522. PubMed ID: 32282405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Censored patients in Kaplan-Meier plots of cancer drugs: An empirical analysis of data sharing.
    Rosen K; Prasad V; Chen EY
    Eur J Cancer; 2020 Dec; 141():152-161. PubMed ID: 33160265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-difference curves can be used to communicate time-dependent effects of adjuvant therapies for early stage cancer.
    Coory M; Lamb KE; Sorich M
    J Clin Epidemiol; 2014 Sep; 67(9):966-72. PubMed ID: 24794698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Statistical Analysis Between "Real" Patients Reported in Kaplan-Meier Curves and "Reconstructed" Patients Estimated Through the IPDfromKM Method: Analysis of Eight Trials Evaluating Catheter Ablation of Ventricular Tachycardia.
    Messori A; Fadda V; Romeo MR; Veneziano S; Trippoli S
    Cureus; 2023 Oct; 15(10):e47891. PubMed ID: 37905162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
    Stavridi F; Kalogeras KT; Pliarchopoulou K; Wirtz RM; Alexopoulou Z; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
    PLoS One; 2016; 11(10):e0164013. PubMed ID: 27695115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical divergence measure for survival distributions that can be estimated from Kaplan-Meier curves.
    Cox TF; Czanner G
    Stat Med; 2016 Jun; 35(14):2406-21. PubMed ID: 26842429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
    Royston P; Parmar MK; Altman DG
    J Natl Cancer Inst; 2008 Jan; 100(2):92-7. PubMed ID: 18182621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaplan-Meier Survival, Actuarial Survival, Censoring, and Competing Events-What Is What?
    Hage A; Hage F
    Ann Thorac Surg; 2022 Jul; 114(1):40-43. PubMed ID: 35367199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kaplan-Meier analysis in urological practice].
    Rink M; Kluth LA; Shariat SF; Fisch M; Dahlem R; Dahm P
    Urologe A; 2013 Jun; 52(6):838-41. PubMed ID: 23703691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.
    Wang X; Bai F; Pang H; George SL
    J Biopharm Stat; 2019; 29(4):592-605. PubMed ID: 31286838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drawing Guideline for
    Kim J
    J Korean Med Sci; 2019 Mar; 34(8):e35. PubMed ID: 30833878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaplan-Meier Type Survival Curves for COVID-19: A Health Data Based Decision-Making Tool.
    Calabuig JM; García-Raffi LM; García-Valiente A; Sánchez-Pérez EA
    Front Public Health; 2021; 9():646863. PubMed ID: 34760856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.